Annals of Family Medicine 3:422-429 (2005)
© 2005 Annals of Family Medicine, Inc.
doi: 10.1370/afm.389
Antibiotic Treatment and Survival of Nursing Home Patients With Lower Respiratory Tract Infection: A Cross-National Analysis
Robin L. Kruse, PhD1,
David R. Mehr, MD, MS1,
Jenny T. van der Steen, PhD2,3,4,
Marcel E. Ooms, MD, PhD2,3,
Richard W. Madsen, PhD5,
Ashley K. Sherman, MA5,
Ralph B. DAgostino, PhD6,
Gerrit van der Wal, MD, PhD3,4 and
Miel W. Ribbe, MD, PhD2,3
1 Department of Family and Community Medicine, University of Missouri-Columbia, Columbia, Mo
2 Department of Nursing Home Medicine of the VU University Medical Center, Amsterdam, The Netherlands
3 Institute for Research in Extramural Medicine (EMGO Institute) of the VU University Medical Center, Amsterdam, The Netherlands
4 Department of Public and Occupational Health of the VU University Medical Center, Amsterdam, The Netherlands
5 Biostatistics Unit, Office of Medical Research, University of Missouri-Columbia, Columbia, Mo
6 Mathematics and Statistics Department, Boston University, Boston, Mass

View larger version (32K):
[in a new window]
|
Figure 1. Antibiotic administered to nursing home residents with a lower respiratory tract infection, by nation and stratum of predicted risk of 1-month mortality.
IM = intramuscular; TMP-SMX - trimethoprim-sulfamethoxazole.
|
|


View larger version (34K):
[in a new window]
|
Figure 2. Predicted and actual 1- and 3-month mortality, by decile of predicted mortality risk for US and Dutch residents.
The dotted line indicates ideal discrimination, where predicted and actual mortality are equal.
|
|
Copyright © 2005 by the Annals of Family Medicine.